chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was fully vaccinated against COVID-19 on March 12, 2021. Patient hospitalized with COVID-19 on 9/14/2021. She is currently still hospitalized and estimated to stay the weekend. Today is 9/17/2021.
sore throat, runny nose, intermittent fevers, dyspnea, malaise acute, sub-massive PE with right heart strain and hypotension
On Saturday 01/23/2021 morning when I got out of bed I experienced difficulty maintaining my balance. I had to use a wall to be able to stand. I did not fall. I stumbled into the bathroom, still unsteady. I urinated sitting down, still feeling unsteady, head spinning. I took my blood pressure 130/70, which is normal. Was feeling steadier. Was able to walk down stairs to ground floor of home. Still not felling normal, but steady on my feet. After eating breakfast, no additional symptoms through day. I had not consumed any alcoholic beverages over the past week. When I went to bed Sat night, lying in bed I was light headed. Sunday morning same problems. I performed some vehicle maintenance and would get down on the ground. Head would start spinning, everything would return to normal once standing. At bedtime same feelings when lying down in bed. Monday morning (today) same problems.
arm soreness; pain; This case was reported by a consumer and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm and pain. On an unknown date, the outcome of the pain in arm and pain were unknown.   It was unknown if the reporter considered the pain in arm and pain to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. The age at vaccination was not reported. After receiving Shingrix, the patient experienced arm soreness and pain. The patient did not receive 2nd dose because of arm soreness and pain. The reporter consented to follow up. This was 1 of 5 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021054377:same reporter
After the second dose, that night, I started getting stiffness in my joints. So I was stiff and couldn't move my joints at all and was trying to find something to keep them working, then on the June 21st 2021 I ended up at the ER because my knee was swelled so bad it was about four times the size of it should be. The DR gave me pain cream and steroids to try and help but it ended up needing to  be drained on 15th of July and a cortisone shot in my knee at the specialist. Then I talked to several friends and they have had effects to their arthritis as well.
Hurt Worse Than COVID-19 Vaccination; Arm Was Sore; This case was reported by a consumer via interactive digital media and described the occurrence of injection site pain in a 71-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included COVID-19 VACCINE UNKNOWN with an associated reaction of pain (received dose on an unknown date).   On 2nd July 2021, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than 2 months after receiving Shingles vaccine, the patient experienced injection site pain and pain in arm. On an unknown date, the outcome of the injection site pain was unknown and the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the injection site pain and pain in arm to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient took the 1st shot in 2nd July 2021 and it hurt worse than covid-19 vaccination and the arm was sore for a whole week but the patient believed it was worth it. The patient heard that shingles was no joke, also said that he/she would take 2nd dose in 9th September 2021. No contact details were reported.
After 15 minutes, PT c/o itching at back of neck.  PT had large welt/hives that spread to arms within minutes.  PT was immediately taken to acute care, IV access was obtained, IV Benadryl (12.5 mg IV) was given.  Less than 20 minutes after receiving VAQTA (Hep A dose #2) PT developed swelling of tongue and lips.  12.5 mg of Benadryl was repeated.  All hives and swelling resolved and patient was discharged with PO Benadryl, methylprednisolone dose pack (PO), Zyrtec, and Epi-pen (all with instructions) and has appointments for follow up and with an allergist.
Patient is concerned about where injection was given.  She reports pain at the site of injection and feels it was injected too high in her arm.   She called and PCP and we did also.  She has been seen as a result of her pain.
received vaccine left deltoid 5/21/2018. Experienced very sore shoulder and flu-like symptoms. initial shoulder pain post vaccine lasted about 2 weeks, flu symptoms resolved in about 7 days. 7/18 started to develop left pain shoulder, became chronic in nature. finally saw orthopedic specialist, for inflammation 3/19 and attended PT without relief. Returned to Orthopedic doctor 5/19 and was diagnosed with frozen shoulder -adhesive capsulitis . Correlation between initial vaccination and start of inflammation leading to condition. Physical therapy continues to improve ROM of L shoulder.
Pain in both kidneys. There have been urine, blood, sonogram, and x-ray testing done. No reason for the pain has been found yet. Still under going testing. There has been some improvement, but intermittent pain still occurring.
Left hip erythema at injection site 3cmx5cm diameter. No induration, swelling - advised ice to area, OTC Advil every 4 hours.
Mild Brain pause; Unable to think clearly; Vision Problem; Pressure in her head; This spontaneous case was reported by a consumer and describes the occurrence of MENTAL IMPAIRMENT (Mild Brain pause) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical report provided by the reporter.  Concurrent medical conditions included Hypertension. Concomitant products included ATENOLOL for Hypertension.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENTAL IMPAIRMENT (Mild Brain pause) (seriousness criterion medically significant), THINKING ABNORMAL (Unable to think clearly), VISUAL IMPAIRMENT (Vision Problem) and HEAD DISCOMFORT (Pressure in her head). At the time of the report, MENTAL IMPAIRMENT (Mild Brain pause), THINKING ABNORMAL (Unable to think clearly), VISUAL IMPAIRMENT (Vision Problem) and HEAD DISCOMFORT (Pressure in her head) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. The rechallenge was positive.   This case was linked to MOD-2021-114463 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Entire upper thigh swollen, 8-inch around redness, splotching, tenderness. Took to ER on 8/10, diagnosed with cellulitis, prescribed 2 antibiotics.
Very tired; headaches; This is a spontaneous report from a contactable consumer, the patient. An 85-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot EN5318, first dose) solution for injection intramuscular in the left arm on 29Jan2021 at 13:15 (at the age of 85-years-old) at single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included blood pressure and known allergies: penicillin. Concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 03Feb2021 at 07:00, the patient experienced very tired and headaches. No treatment was provided for the events very tired and headaches. The outcome of the events very tired and headaches was not recovered. Since the vaccination, the patient has not been tested for COVID-19.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 29-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history was not reported. The patient took concomitant medications (reported as patient received other medications in two weeks of starting COVID-19 treatment). The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid started on 19May2022 and stopped on 24May2022. Clinical course was reported as, Covid symptoms rebound 5 days from last paxlovid dose on 28May2022. No treatment received for symptoms and patient was recovering from symptoms.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information provided in the narrative, a causal association between the suspect drug and the events cannot be completely excluded.
13 hours after getting the booster, I had this nervy wave feeling coming over me. It felt like a nerve thing going up and down my body. I had pins and needles on both arms and hands. The scar on my left side had the feeling of pins and needles. A few hours later it progressed to sharp prickles on my back, neck, thighs, pubic area, and ankles. I also had buzzing and vibrating in my arms and hands through the next night. I had an undulating vibration in feet 3 days later. It felt like ocean waves. On the 16th I found a chiropractor who did a lot of different techniques. After her treatment all symptoms went away except for the pins and needles in my arms and hand. The symptoms returned on March 11, 2022, but were milder. On March 21, I went back to the chiropractor who did additional techniques and 5 days later, I woke up with no symptoms. On March 28, while eating pita chips, I felt like something was stuck in my esophagus. I had to have my husband get off to get hot water in order to break down the particles. I have an appointment with an ENT and he had me to do a Esophagram and indicated I had transient resistance in my esophagus. I am seeing an acupuncturist now as well. I am having an EGD test done to look at my esophagus function.
This spontaneous report was received from a physician concerning a female patient of unknown age. On an unknown dates, approximately in 2011 (2 years ago), the patient was vaccinated with dose 1 and dose 2 of GARDASIL (lot number, expiry date, dose and route unspecified) and the patient would like to receive her dose 3 of GARDASIL (lot number and expiry date unspecified) at the time of reporting. No concomitant medications were reported. Additional information has been requested.
Severe arm pain - all the way down the arm, around the should joint including armpit and upper trap and neck. Numbness in left cheek and radiating and tingly feeling through the wrist and fingers -  immediate onset. Left arm only where the shot was given. 48 hours later the pain is still present. Severity of the pain is severe and can't move left arm since the vaccine.   Acetaminophen 500 mgs is being taken and is helpful, but doesn't eliminate the pain.
The patient was eating lunch,  began yelling out, the speech was slurred, right side of the face drawn, grips unequal (right side), pale and diaphoretic. FBS 148. the resident was alert. vitals obtained 198/109, pulse 88, o2 98% RA. notified EMS of emergency - Sent to ER to R/O Stroke
fever; This case was reported by a physician and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was recovered/resolved.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was selected as adult as per vaccine indication. The patient received 1st dose of Shingrix and experienced fever. The reporter consented to follow up. The case was linked with the case US2021010470, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021010470:same reporter
The day after vaccination pt developed a red, itchy rash about 5 inches in diameter around the injection site.
Breakthrough case admission after 2 vaccines Pfizer 3/18/21 Lot# EN6207;  Pfizer 4/8/21 Lot# Ew0150
This spontaneous report as received from Nurse refers to a patient of unknown demographics. The patient concurrent conditions, medical history and concomitant medications were not reported. On 22-AUG-2017, the patient was vaccinated with first dose of GARDASIL 9 when the patient was 11 year old. On 08-FEB-2018, the patient received second dose of GARDASIL 9 earlier than the 6 months minimal requirement for a two dose interval. No product quality compliant reported.
Pain and swelling at injection site starting 1 day after shot and worsening; numbness into hand.
On 4/24/02, in the night, she woke up screaming and said she saw spiders coming at her and she tried to wipe them off her hands. This lasted about 2 hours. Pediatrician called. No treatment. Told if it continued, to go to MD. The next night it quit and then the she saw spiders the following night. On 4/8/02, she had her 1st Hep-A at PMD. She was started on Suprax for UTI for 10 days.
Initial and follow up information has been received via the Merck pregnancy registry, from a registered nurse, concerning an 18 year old female with no known allergies and a history of chlamydial infection (2006), who on 27-NOV-2006 was vaccinated IM in the left arm, with the first dose, 0.5ml, of Gardasil (Lot #653937/0637F), and on 29-JAN-2007 with the second dose, IM in the left arm, 0.5ml, of Gardasil (Lot #655617/1447F). On 30-APR-2007, the patient presented to the office, and a urine pregnancy test performed was positive; other labwork was within normal range. The patient reported a questionable LMP date of 09-APR-2007, with an estimated date of delivery of 14-JAN-2008. Follow up information included that on 30-APR-2007, prenatal vitamins (PRIMACARE ONE) were initiated. On 04-OCT-2007, an ultrasound was performed for routine prenatal care (result not specified). There were no illnesses or infections during pregnancy. The patient experienced complications during labor and delivery, due to uterine atony and a non-reassuring fetal heart rate and a Cesarean section was required; however, on 28-DEC-2007, at 41 weeks gestation, she delivered a normal female infant (no abnormalities and no congenital anomalies), weight 8 lb 1oz, Apgar score 8/9. Upon internal review, non-reassuring fetal heart rate and uterine atony were considered to be serious as other important medical events. Additional information is not expected.
Everyday since vaccination fever of 99.5 (no higher ), chills, headache, extreme tiredness (sleeping 15-18 hours per day)
RN reports vaccination is expired.  Bad headache, Runnynose, Nausea
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 07Oct2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 67 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (24Dec2022) Negative, notes: had negligible symptoms and a negative covid test on 24Dec2022; (30Dec2022) Positive, notes: positive test with mild symptoms on 30Dec2022. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information included as patient had negligible symptoms and a negative covid test on 24Dec2022, a day after completing Paxlovid treatment, and a positive test with mild symptoms on 30Dec2022.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Information has been received from a pharmacist doctor concerning a 68 year old female with allergy to sulfa drugs and with no medical history who on 30-APR-2010 was vaccinated with ZOSTAVAX (Merck) (lot# not reported). Concomitant therapy included losartan potassium (MSD) and lisinopril (manufacturer unknown). In July 2010 the patient went to the pharmacist office and informed her that she had experienced rash predominantly on the right side of her face along her "facial nerve" that had reoccurred every month since getting the ZOSTAVAX (Merck). The pharmacist stated that the patient had seen her medical doctor regarding this rash. At the time of the report the patient's status was unknown. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to unspecified number of patients of an unknown age and gender. There was no information about patients' concomitant medications pertinent medical histories, drug reactions and allergies provided. On unspecified dates, the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX (lot #, L006386, expiration date 25-FEB-2017; lot # L000454, expiration date 06-JAN-2017; lot # K020760,, expiration date 31-OCT-2016; lot # K016128, expiration date 23-SEP-2016; doses, routes and sites of administration were not reported). No adverse events were reported. No product quality complaints (PQC) were involved. This is one of several reports received from the same reporter. Additional information has been requested.
Vaccine (PEDIARIX, Hib (OMP), PREVNAR, ROTARIX) given 7/21. On 7/23 sudden onset of repeated stiffening arm, legs, arching back and grimace for several seconds. He did not eat. Seen in ER - no findings and diagnosed 'reflux' - symptoms stopped after 12 hrs. and normal.
Great fatigue, fever to 102 degrees, chills, headache, body aches, nausea, constant coughing.  Sick from Sunday afternoon until Tuesday night.  All symptoms resolved, except fatigue continued for a couple more days.
Mom walked in with pt earlier today for concern of redness and swelling at injection site. Mom states after her 4yr WCC and shots, mom took her home and gave a 'nice warm bath" and then she noted that her R upper back of arm started to "swell up'.
This case was reported by a nurse and described the occurrence of inappropriate age at vaccine administration in a 2-year-old female patient who received FLULAVAL quadrivalent (batch number 5ZT94, expiry date 1st June 2015). On an unknown date, the patient received by accident FLULAVAL quadrivalent .5 ml. On an unknown date, an unknown time after receiving FLULAVAL quadrivalent, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. It was unknown if the reporter considered the inappropriate age at vaccine administration to be related to FLULAVAL quadrivalent.
I woke up the morning of 3/23/2021 approximately 5am with a ringing in my left ear.  It has been constant since that time.  I should add to the other that my blood pressure has elevated since the vaccine.  As part of going on medication on 3/18, it was a concern the medications would elevate my blood pressure.  I bought a wrist BP check device and it was averaging 134/95 on 3/22/2021.  On 3/23/2021, I was prescribed Losartan.  I took one pill at 7:30PM.  Today when I woke up and for most of the day the BP has been 124/77-82.  The ringing remains persistent
Information has been received from a physician concerning a 15 year old female with a history of fainting twice in the past who on 25-SEP-2008 was vaccinated with the first dose of GARDASIL (LOT# 661530/0575X). The patient also received MENACTRA at the same visit. The patient said that the injection was painful. She went into a seizure immediately after the injection and passed out for about 30 seconds. The physician pulled her hair back and she came to. The physician thought that this was a vasovagal reaction. Subsequently, the patient recovered from the events in the same day. An electrocardiogram was scheduled for the patient as follow-up. The patient sought medical attention. Upon internal review, seizure was determined to be an other important medical event. Additional information has been requested.
I contracted COVID-19. I had a high fever of 104 for over a week, sore throat, body aches, cough, chills, night sweats, headache, and I lost my sense of smell. My heart would race as well. I did not get PAXLOVID because my doctor said it would interact with the anti-depressant I was on. I just took TYLENOL and ADVIL instead. The doctor said that I now have long COVID-19. I was diagnosed with Tachycardia and I have heart palpitations. I am under the care of a cardiologist now.
#6 ANTHRAX given SQ and SM developed redness, swelling, pain at injection site within 24 hrs of getting vaccine, area approx 4-5 inches. Treated with OTC MOTRIN. Did not miss any work or PT time. All symptoms resolved with in one week. Symptoms: Erythema, Swelling, Edema @ injection site 50-120mm, Pain.
This is a spontaneous report from a contactable consumer (patient). A 30-year-old (non-pregnant) female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 30, via an unspecified route of administration, in the left arm, on May 4, 2021, at 03:00, single dose, for COVID-19 immunisation. No medical history or concomitant medications reported. Prior to the vaccination, patient was not diagnosed with COVID-19. On May 5, 2021, patient experienced loss of taste. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the event. Since the vaccination, patient has not tested for COVID-19. The outcome of loss of taste: not resolved (at the time of report). No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
This was my third shot, booster.  Had a 100 degree fever and was achy and tired.  Those were all fine as I experienced them before after shot number 2.  This time however I have a swollen lymph node in my armpit as well as my neck/collerbone are.  Both are tender and sore.